Join TB Alliance at the (virtual) 51st Union World Conference on Lung Health, taking place online on 20 - 24 October 2020. Follow our live coverage on Twitter using @TBAlliance and #UnionConf.
Monday, 19 October
Working Group on New Drugs Annual Meeting
9:00AM-12:00PM ET | 15:00-18:00 CEST
The Stop TB Partnership Working Group on New Drugs’ Annual Meeting is a neutral forum bringing together those working in research and development to get a full understanding of the progress, challenges, and critical issues to developing TB treatments. The 2020 WGND Annual Meeting is taking place on Monday, 19 October at 9AM -12PM ET. The meeting will take place over Zoom Webinar and speakers will include representatives from AIDS Clinical Trials Group (ACTG), Qurient, PanACEA, Janssen, GSK, Gates Medical Research Institute (GMRI), the TB Drug Accelerator (TBDA), U.S. Centers for Disease Control and Prevention (CDC), TB Alliance, Otsuka, Merck, and others. Please register here to participate.
Tuesday, 20 October - Saturday, 24 October
Louder Than TB (Virtual) Exhibit Booth
When the world agreed to cough it up for TB, this is not what anyone had in mind. Join the #LouderThanTB coalition at our virtual exhibit booth to find out more about how we can all raise our voices and speak directly to world leaders and decision-makers. It's long past time to put TB back on the global agenda. Visit www.LouderThanTB.org/CoughItUp to learn more and help promote change.
Wednesday, 21 October
Introducing LIFT-TB (Leveraging Innovation for Faster Treatment of Tuberculosis)
7:00-8:00 ET | 13:00-14:00 CEST | 20:00-21:00 KST
TB Alliance announced a new initiative called LIFT-TB (Leveraging Innovation for Faster Treatment of TB) on 21 October at 1PM CEST. The launch event focused on the introduction of new TB therapies and featured critical voices in the global fight against tuberculosis. The session was moderated by Saurabh Rane, MD, activist and XDR-TB survivor.
- Sandeep Juneja, SVP, Market Access, TB Alliance
- Teak Keun Lee, Director General, Global Disease Eradication Fund Department, KOICA
- Tauhid Islam, MD, Coordinator, End TB and Leprosy, WHO WPRO
- Vineet Bhatia, MD, Medical Officer, WHO SEARO
- Celina Garfin, MD, NTP Manager, Philippines
- Nataliia Lytvynenko, MD, Head DR-TB Research, NAMSU and Principal Investigator, BPaL Operational Research, Ukraine
- Zaw Myint, MD, Senior Consultant, NTP Myanmar
Thursday, 22 October
Oral Abstract Presentation: Pretomanid added to bedaquiline and linezolid for patients with extensively-drug resistant TB and multidrug-resistant TB treatment failure or intolerance: a comparison of prospective cohorts
6:30-7:50 ET | 12:30-13:50 CEST | Channel 7
Suzette Oelofse, MD, University of Cape Town, will present findings on how the Phase 3 Nix-TB clinical trial—which evaluated a new treatment regimen for people with XDR-TB or treatment-intolerant or non-responsive MDR-TB—compared to a prospectively recruited XDR-TB cohort. This virtual Oral Abstract Session will be on Channel 7. Please see the online programme for additional details.
Coming Soon: Thursday, 19 November
TB Alliance Stakeholder's Association Annual Meeting
8:30-10:00 ET | 14:30-16:00 CEST
TB Alliance is convening its annual Stakeholders Association (SHA) meeting as a virtual event this year. Nick Herbert (Lord Herbert of South Downs), Chair of the Global TB Caucus and Chair of the Global Equality Caucus will be a keynote speaker. Additional details will be shared along with an invitation closer to the event. This meeting will be taking place via Zoom. Please register here.